Genomtec

Point-of-care molecular dx · Rapid infectious-disease testing

Overview

Lab-on-chip isothermal amplification (SNAAT) for decentralized molecular diagnostics.

What they do

Genomtec is a Polish molecular-diagnostics company founded in 2016 and headquartered in Wroclaw, with roots in molecular biology, microfluidics and photonics. It develops decentralized, point-of-care testing built on its proprietary SNAAT (Streamlined Nucleic Acid Amplification Technology), which combines LAMP-based isothermal amplification with microfluidics and a patented contactless optical heating and detection system.

Lead program & status

Its flagship product, Genomtec ID, is a portable analyzer plus disposable reaction card that runs sample preparation, amplification and detection of pathogen DNA/RNA without a central lab, reportedly delivering results in roughly 15-25 minutes with multiplexing of up to five targets. As of 2024 the company reported signing a conditional agreement with a UK-based CDMO to manufacture the analyzer and obtaining US (USPTO) patent allowance for its core detection method, advancing toward commercialization.

Why it matters

Genomtec aims to bring lab-grade molecular accuracy to clinics, pharmacies and emergency settings, supporting faster decentralized infectious-disease diagnosis across Europe and beyond.

FAQ

What is SNAAT?

Streamlined Nucleic Acid Amplification Technology - Genomtec's isothermal (LAMP-based) chemistry paired with microfluidics and a contactless optical heating and detection system.

How fast is Genomtec ID?

The platform reportedly delivers results in approximately 15-25 minutes and can detect up to five genetic targets at once.

Where is Genomtec based?

Genomtec is headquartered in Wroclaw, Poland, and was founded in 2016.

Company website / source ↗ Open the interactive map →